GBB (Gamma-Butyrobetaine)

Evidence Level
Preliminary
1 Clinical Trial
3 Documented Benefits
1/5 Evidence Score

GBB (gamma-butyrobetaine, also called gamma-butyrobetaine ethyl ester in supplement form) is the direct metabolic precursor to L-carnitine in human biosynthesis — and is marketed as 'super carnitine' on the idea that it makes the body produce more L-carnitine rather than supplying carnitine directly. GBB is converted to L-carnitine by the enzyme gamma-butyrobetaine hydroxylase (BBH), which can in principle raise plasma L-carnitine. GBB also increases trimethylamine N-oxide (TMAO), a blood marker linked in observational studies to cardiovascular risk, and commonly causes intense sweating. No human trial has tested GBB for fat loss, thermogenesis, or exercise performance.

Studied Dose No human trial has established a dose. Fat-burner labels use about 10-25 mg/day of GBB ethyl ester; these are label amounts, not clinically studied doses.
Active Compound Gamma-butyrobetaine (4-trimethylaminobutyric acid) or its ethyl ester (GBB-EE); endogenous carnitine precursor.

Benefits

Endogenous L-carnitine elevation

GBB is the immediate biosynthetic precursor to L-carnitine — in principle supplemental GBB could raise L-carnitine through the body's own BBH enzyme pathway. This has not been tested in a human supplementation trial, and there is no human evidence that GBB raises carnitine more effectively than taking L-carnitine directly. In rats, high dietary GBB paradoxically reduced endogenous carnitine biosynthesis. This carnitine elevation supports fatty acid transport into mitochondria for oxidation.

Thermogenic sweating

GBB users commonly report intense sweating, even at rest. Sweating is a loss of water and heat, not a measure of fat oxidation. No human trial has measured fat loss, fat oxidation, or thermogenesis with GBB, so the sweating cannot be read as fat burning; it is a visible physiological response, not evidence of an effect on body fat.

Exercise performance and fat oxidation

The L-carnitine elevation from GBB supports fat oxidation during exercise by facilitating long-chain fatty acid transport across the inner mitochondrial membrane via carnitine palmitoyl transferase (CPT1/2) — the rate-limiting step in fat burning during aerobic exercise. Higher carnitine availability is proposed to improve the fat-to-carbohydrate utilization ratio during aerobic exercise. This is extrapolated from L-carnitine physiology: no human trial has measured endurance, glycogen sparing, or exercise performance with GBB itself.

Mechanism of action

1

BBH enzyme conversion to L-carnitine

Gamma-butyrobetaine hydroxylase (BBH) in the liver and kidneys converts GBB to L-carnitine via hydroxylation at the 3-position, requiring vitamin C and Fe²⁺ as cofactors. Supplemental GBB saturates the BBH pathway beyond normal dietary supply, driving elevated L-carnitine biosynthesis. The resulting plasma carnitine elevation improves carnitine availability in skeletal muscle and heart, supporting beta-oxidation of long-chain fatty acids during both rest and exercise. Excess carnitine not oxidized generates butyrobetaine which is excreted, preventing excessive accumulation.

Clinical trials

1
Rat carnitine-biosynthesis study (no human GBB efficacy trial exists)
PubMed

GBB-EE (gamma-butyrobetaine ethyl ester) is the immediate biosynthetic precursor of L-carnitine. Currently published clinical evidence in humans is limited — primarily preclinical/animal data and early human pharmacokinetic observations.

Animal study. Male weanling rats fed carnitine-free diet supplemented with GBB or carnitine isomers for 32 days. Not a human clinical trial — GBB does not have a dedicated PubMed-indexed human clinical trial for performance/sweat/thermogenic effects despite popular consumer claims.

GBB (gamma-butyrobetaine), the immediate precursor to L-carnitine in the biosynthesis pathway, modulated tissue and serum L-carnitine concentrations in rats in a dose-dependent manner. However, dietary GBB at 1% paradoxically reduced endogenous carnitine biosynthesis. This is foundational mechanism work. Caveat: GBB is widely used in supplement formulations (especially fat burners) for its claimed thermogenic/sweat-inducing effect, but there are NO PubMed-indexed human clinical trials validating sustained thermogenic, fat-burning, or performance benefits in humans. Some pharmacokinetic work exists (Vaz 1998 cDNA encoding human GBB hydroxylase) but efficacy claims are extrapolated from carnitine literature, not GBB-specific human trials.

Side effects and drug interactions

Common Potential side effects

Intense thermogenic sweating — normal and expected; not harmful but socially noticeable
Raises TMAO (trimethylamine-N-oxide); the fishy body odor reflects TMAO production. TMAO is a blood marker linked in observational studies to higher cardiovascular risk, so repeatedly raising it is a genuine safety consideration, not only a cosmetic odor. People with heart or vascular disease should be cautious.
Start at lowest effective dose (10 mg); sensitivity varies widely between individuals
Not for use during pregnancy or if you have kidney disease (carnitine metabolism implications)

Important Drug interactions

Blood thinners — carnitine may have mild anticoagulant effects; monitor
Thyroid medications — high carnitine levels may affect thyroid hormone metabolism; monitor
No established pharmacokinetic drug interactions at 10–25 mg/day doses

Frequently asked questions about GBB (Gamma-Butyrobetaine)

What is GBB used for?

GBB (gamma-butyrobetaine) is the direct precursor the body uses to make L-carnitine. It is marketed in fat-burners as a super-carnitine that boosts the body's own carnitine production and may increase sweating and thermogenesis.

What does GBB do?

By raising the body's natural carnitine synthesis, GBB is promoted for fat metabolism and energy, and it noticeably increases sweating, which is why it appears in sweat-inducing pre-workouts and fat-burners. Human evidence for fat loss is limited.

How much GBB should I take?

Doses in supplements are small (often a few to tens of milligrams); follow product labeling, and start low because of the strong sweating effect.

Is GBB safe?

It is generally tolerated, with heavy sweating being the most noticeable effect (so stay hydrated). Long-term human safety data is limited, and it may affect TMAO levels (a cardiovascular marker), so those with heart concerns should be cautious and check with a doctor.

What is GBB?

GBB (gamma-butyrobetaine, also called gamma-butyrobetaine ethyl ester in supplement form) is the direct metabolic precursor to L-carnitine in human biosynthesis — and is marketed as 'super carnitine' on the idea that it makes the body produce more L-carnitine rather than supplying carnitine directly.

What is the recommended dosage of GBB?

The clinically studied dose is No human trial has established a dose. Fat-burner labels use about 10-25 mg/day of GBB ethyl ester; these are label amounts, not clinically studied doses. Always follow the product label and check with a healthcare provider for personal advice.

Is GBB safe, and does it have side effects?

For most healthy adults, GBB is well tolerated at studied doses. Reported effects can include: Intense thermogenic sweating — normal and expected; not harmful but socially noticeable Raises TMAO (trimethylamine-N-oxide); the fishy body odor reflects TMAO production. It may also interact with some medications. GBB is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does GBB interact with any medications?

Possible interactions include: Blood thinners — carnitine may have mild anticoagulant effects; monitor Thyroid medications — high carnitine levels may affect thyroid hormone metabolism; monitor If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for GBB?

NutraSmarts rates the evidence for GBB as Preliminary (1 out of 5). It is backed by 1 clinical trial and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Primassin S, Spiekerkoetter U ESI-MS/MS measurement of free carnitine and its precursor gamma-butyrobetaine in plasma and dried blood spots from patients with organic acidurias and fatty acid oxidation disorders Molecular Genetics and Metabolism. 2010;101(2-3):141-5. doi: 10.1016/j.ymgme.2010.06.012.PubMedUsed to support: Quantifies gamma-butyrobetaine and free carnitine by tandem mass spectrometry in plasma and dried blood spots from patients with fatty acid oxidation disorders and organic acidurias. It establishes gamma-butyrobetaine as the measurable biochemical precursor of L-carnitine in humans, and notes that in low-carnitine patients elevated gamma-butyrobetaine is not evidence of induced carnitine biosynthesis. An analytical method study, not an intervention trial; it did not administer GBB or measure any efficacy outcome.
  2. Grinberga S, Dambrova M, Latkovskis G, Strele I, Konrade I, Hartmane D, Sevostjanovs E, Liepinsh E, Pugovics O Determination of trimethylamine-N-oxide in combination with L-carnitine and gamma-butyrobetaine in human plasma by UPLC/MS/MS Biomedical Chromatography. 2015;29(11):1670-4. doi: 10.1002/bmc.3477.PubMedUsed to support: Develops and validates a UPLC/MS/MS method to measure TMAO together with L-carnitine and gamma-butyrobetaine in human plasma, applied to samples from healthy volunteers. It confirms these related molecules can be quantified together but is an analytical method study, not an intervention trial, and measures no fat-loss, thermogenic, or performance outcome.
  3. Rebouche CJ. Effect of dietary carnitine isomers and gamma-butyrobetaine on L-carnitine biosynthesis and metabolism in the rat. J Nutr. 1983;113(10):1906-13. doi: 10.1093/jn/113.10.1906.PubMedUsed to support: Male weanling rats were fed a carnitine-free diet supplemented with carnitine isomers or gamma-butyrobetaine for 32 days. L-carnitine supplementation raised carnitine in serum and tissues, but gamma-butyrobetaine at 1 percent of the diet reduced carnitine biosynthesis from trimethyllysine. This is the animal study underlying the page's one trial card; it is not human and measured no fat-loss, thermogenic, or performance outcome.